<DOC>
	<DOCNO>NCT02379572</DOCNO>
	<brief_summary>Standard treatment glioblastoma ( GBMs ) consist microsurgical resection follow concomitant chemoradiation . The extent resection one important prognostic factor significant influence survival patient . State art technique achieve radical resection possible conventional surgery fluorescence-guidance 5-aminolevulinic acid ( 5-ALA ) . If available , intraoperative MRI ( iMRI ) -guided tumor resection enable intraoperative resection control subsequent continuation surgery contrast enhance tumor remnant find . Therefore radical resection longer survival patient might possible . To date comparison two lead technology GBM-surgery available identify best surgical therapy fatal disease justify significant healthcare-economic difference technology . Goal study ass value iMRI guidance resection GBMs comparison conventional 5-ALA microsurgery . Primary endpoint number total resection ( residual contrast enhancement ) postoperative MRI ( T1+CM within 48 hour surgery ) group . Secondary endpoint perioperative clinical data , progression free survival , patient ' clinical condition overall survival . The study design choose parallel-group approach compare iMRI 5-ALA center ( n=13 ) exclude possible bias might find randomize patient within individual iMRI center surgeon experience possible use respective technology .</brief_summary>
	<brief_title>Impact iMRI Extent Resection Patients With Newly Diagnosed Glioblastomas</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Aminolevulinic Acid</mesh_term>
	<criteria>1 . In MRI suspect primary singular untreated GBM 2 . Planned total resection tumor accord surgeon 3 . Patient ≥18 year , ≤80 year 4 . Preoperative KPS ≥ 60 % , American Society Anesthesiologists ( ASA ) score 1 2 5 . Patients ' inform consent 1 . Tumors midline , basal ganglion , cerebellum , brain stem , eloquent area 2 . Multifocal glioblastoma 3 . Substantial ( &gt; 50 % ) , noncontrast enhance tumor area suggest lowgrade glioma malignant transformation 4 . Contraindications MRI 5 . Inability give consent language barrier dysphasia 6 . Histological diagnosis Glioblastoma multiforme WHO °IV 7 . Increased risk thrombosis ( e.g . Factor V Leiden ) 8 . Pregnancy breast feed 9 . Hypersensibility 5ALA oder porphyrin 10 . Acute chronic Porphyria 11 . Renal insufficiency 12 . Hepatic insufficiency 13 . High likelihood inability receive adjuvant therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>5-ALA</keyword>
	<keyword>Intraoperative MRI</keyword>
	<keyword>Extent resection</keyword>
</DOC>